Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Verastem Oncology (VSTM) will present at the RBC Capital Markets Global Healthcare Conference, demonstrating commitment to advancing cancer treatments. The management team will participate in a fireside chat on May 14, 2024. The webcast can be accessed on the company's website.
- None.
- None.
A live webcast of the fireside chat can be accessed under events on the Verastem Oncology’s website at www.verastem.com. A replay of the webcast will be archived on the website for approximately 90 days following the presentation.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240507625461/en/
For Investor and Media Inquiries:
Julissa Viana
Vice President, Corporate Communications and Investor Relations
investors@verastem.com or
media@verastem.com
Source: Verastem Oncology
FAQ
When will Verastem Oncology present at the RBC Capital Markets Global Healthcare Conference?
Where can the webcast of the fireside chat be accessed?
For how long will the webcast be available for viewing after the presentation?
